Market research
AFP.AU AFT Pharmaceuticals Limited
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 359M
- P/E ratio
- 31.14
- Analyst target
- Not available
- Dividend yield
- 0.7%
- Beta
- 0.46
Community
Investor discussion
1 comment
Sign in to join the AFP.AU discussion.
5 years, 5 months ago
AFT Pharmaceuticals Limited is currently in a long term downtrend where the price is trading 3.6% below its 200 day moving average.
From a valuation standpoint, the stock is 98.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
AFT Pharmaceuticals Limited's total revenue rose by 4.0% to $49M since the same quarter in the previous year.
Its net income has dropped by 88.0% to $1M since the same quarter in the previous year.
Finally, its free cash flow fell by 141.2% to $-1M since the same quarter in the previous year.
Based on the above factors, AFT Pharmaceuticals Limited gets an overall score of 2/5.